About NucleoBio
Vision
NucleoBio is a pioneering leader in molecular biology. Our commitment to innovation, backed by our extensive scientific and clinical expertise, drives our vision to achieve breakthroughs in cancer diagnosis and therapeutics.
Based in the thriving biotech corridor of San Antonio, Texas, we take pride in our minority-owned status and our dedication to cancer research for a healthier future. Join us as we transform the landscape of cancer diagnosis and treatment.
Mission
Our mission is to develop molecular, blood-based tests for early and precise of detection of cancer to save the lives and the quality of life of cancer patients. To do this, we are:
-
Introducing Prostac®, a group of patented molecular-based tests that enable the early detection of prostate cancer with near 100% accuracy.
-
Developing a family of proprietary, molecular-based tests based on our proprietary Molecular Cancer Identification (MCI) Platform that enables the early detection of additional cancers with unparallel accuracy and that empowers physicians to prescribe data-driven and personalized life-saving interventions.
